Jinflexin A
Jinflexin A is a phenanthrene compound that can be extracted and isolated from the roots of the plant Juncus inflexus, and it is also a potential antibacterial agent. Jinflexin A significantly inhibits the proliferation of various human tumor cell lines, with a IC50 range of 12.9 μM to 24.7 μM. Jinflexin A can be used in research related to Methicillin (HY-121544)-resistant Staphylococcus aureus infections, breast cancer, cervical cancer, and ovarian cancer.
For research use only. We do not sell to patients.
- CAS No.: 2055155-75-2
- Formula: C19H22O3
- Molecular Weight:298.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
24.7 μM
|
Antiproliferative activity against human HeLa cervix carcinoma cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human HeLa cervix carcinoma cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
33668621 |
| T47D | IC50 |
14.2 μM
|
Antiproliferative activity against human T-47D ductal carcinoma cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human T-47D ductal carcinoma cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
27808510 |
| A2780 | IC50 |
22.3 μM
|
Antiproliferative activity against human A2780 ovarian cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human A2780 ovarian cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
33668621 |
| A2780cis | IC50 |
16.9 μM
|
Antiproliferative activity against human A2780cis cisplatin-resistant ovarian cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human A2780cis cisplatin-resistant ovarian cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
33668621 |
| MCF7 | IC50 |
12.9 μM
|
Antiproliferative activity against human MCF-7 breast cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human MCF-7 breast cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
33668621 |
| MRC5 | IC50 |
18.9 μM
|
Antiproliferative activity against human MRC-5 embryonic lung fibroblast cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human MRC-5 embryonic lung fibroblast cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
33668621 |
In Vitro
Jinflexin A (0.1953125-100 μM; 72 h) inhibits proliferation of HeLa, HTB-26, T-47D, A2780, A2780cis, MCF-7, KCR human cancer cell lines and MRC-5 normal human fibroblasts, with the strongest activity against MCF-7 cells (IC50 = 12.9 μM) and T-47D cells (IC50 = 14.2 μM)[2].
Jinflexin A (10 mg/mL; 24 h) shows no antibacterial activity against methicillin-resistant Staphylococcus aureus (ATCC43300) in the disk-diffusion assay[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HeLa cervix carcinoma, HTB-26 breast adenocarcinoma, T-47D ductal carcinoma, A2780 ovarian cancer, A2780cis cisplatin-resistant ovarian cancer, MCF-7 breast cancer, KCR doxorubicin-resistant breast cancer, MRC-5 embryonic lung fibroblast
-
Concentration:Two-fold serial dilution from 100 to 0.19 μM
-
Incubation Time:72 h
-
Result:Inhibited proliferation of HeLa cells with an IC50 of 24.7 μM.
Inhibited proliferation of HTB-26 cells with an IC50 of 22.8 μM.
Inhibited proliferation of T-47D cells with an IC50 of 14.2 μM.
Inhibited proliferation of A2780 cells with an IC50 of 22.3 μM.
Inhibited proliferation of A2780cis cells with an IC50 of 16.9 μM.
Inhibited proliferation of MCF-7 cells with an IC50 of 12.9 μM.
Inhibited proliferation of KCR cells with an IC50 of 24.2 μM.
Inhibited proliferation of MRC-5 cells with an IC50 of 18.9 μM.
Chemical Information
-
CAS No. 2055155-75-2
-
Molecular Weight 298.38
-
Formula C19H22O3
-
SMILES
OC(C(C)=C1CC2)=CC(C(OC)C)=C1C3=C2C(C)=C(O)C=C3
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Jinflexin A Related Classifications
HY-N7350 Related Classifications
Powered by Bioz